Syra Health Return on Equity (ROE) Growth & History (SYRA)
Syra Health's return on equity was −36.02% for fiscal 2025.
View full Syra Health company overviewSyra Health annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −36.02% | +73.07 pp |
| 2024 | 2024-12-31 | −109.09% | +15.33 pp |
| 2023 | 2023-12-31 | −124.42% | — |
Syra Health quarterly return on equity
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 10.02% | +12.63 pp |
| Q1 2026 | 2026-03-31 | 10.80% | +28.51 pp |
| Q4 2025 | 2025-12-31 | −6.25% | +10.00 pp |
| Q3 2025 | 2025-09-30 | −9.77% | +5.63 pp |
| Q2 2025 | 2025-06-30 | −2.61% | +47.56 pp |
| Q1 2025 | 2025-03-31 | −17.70% | +21.08 pp |
| Q4 2024 | 2024-12-31 | −16.25% | +55.26 pp |
| Q3 2024 | 2024-09-30 | −15.40% | — |
| Q2 2024 | 2024-06-30 | −50.18% | — |
| Q1 2024 | 2024-03-31 | −38.78% | — |
| Q4 2023 | 2023-12-31 | −71.50% | — |
Syra Health return on equity trends
Between the periods ended 2023-12-31 and 2025-12-31, Syra Health's return on equity increased from −124.42% to −36.02%, a change of +88.40 percentage points. The latest reported quarter, Q2 2026, shows 10.02%.
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Syra Health source filings ↗